Close Menu

Meridian Bioscience

NEW YORK (GenomeWeb) — In an effort to design primers that might solve the conundrum of the plateau effect in PCR amplification, researchers at Ohio State University and Ilia State University in the country of Georgia have created a method called quadruplex priming amplification.

NEW YORK (GenomeWeb) – Meridian Bioscience today announced an agreement with healthcare alliance Premier to offer Meridian's illumigene molecular tests.

NEW YORK (GenomeWeb) – Meridian Bioscience today released its revenue and earnings per share guidance for fiscal year 2015, coming in below Wall Street expectations.

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a slight improvement in its fiscal third quarter sales as it missed consensus Wall Street expectations on the top and bottom lines.

Meridian Bioscience said this week that it has received medical device license approval from Health Canada to market its Illumigene Mycoplasma and Pertussis assays.

NEW YORK (GenomeWeb) – Meridian Bioscience today announced that Health Canada has approved for marketing Meridian's molecular assays for Mycoplasma pneumonia and Bordetella pertussis on the company's illumigene platform.

Meridian Bioscience said this week that it recently hired Michael Shaughnessy as executive vice president and president of Meridian Global Diagnostics.

NEW YORK (GenomeWeb) — Meridian Biosciences today reported a 6 percent year-over-year increase in fiscal second quarter revenues as growth in its Illumigene molecular assay product portfolio helped temper flagging sales of its influenza immunoassay.

Quest Diagnostics said this week that its Focus Diagnostics business has received expedited 510(k) clearance from the US Food and Drug Administration and CLIA moderate complexity categorization for its Simplexa HSV 1&2 Direct molecular test o

NEW YORK (GenomeWeb News) — Meridian Bioscience said today that it has received US Food and Drug Administration clearance for its Illumigene Bordetella pertussis molecular diagnostic test.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.